CNP and cardiovascular disorder: We have examined possible modulation of CNP peptides and ET-1 by statin therapy, as evidenced by change in their circulating levels in a carefully planned prospective study of i) young and older statin naïve subjects without evidence of renal or cardiovascular disease, and ii) older statin naïve subjects with history of a recent coronary occlusive event.